Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19)
Phase 1
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003003
- Lead Sponsor
- Shanghai University of TCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Meet the diagnostic criteria of Novel Coronavirus Pneumonia (COVID-19).
Exclusion Criteria
1. Pregnant or lactating women, allergic to the research drug;
2. Combined with cardiovascular, liver, kidney and hematopoietic systems and other serious primary diseases, mental illness;
3. Those with observational factors affecting efficacy;
4. Those who do not meet the inclusion criteria, do not use the prescribed drugs, can not determine the efficacy or incomplete information and other effects of efficacy or safety judgment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TCM synergy with antiviral agents in ITMCTR2000003003?
How does TCM combination therapy compare to standard-of-care for SARS-CoV-2 viral load reduction?
Which biomarkers correlate with improved outcomes in TCM-Western medicine COVID-19 treatment?
What adverse events are associated with TCM integration in phase I SARS-CoV-2 clinical trials?
Are there competitive herbal compounds showing similar efficacy to TCM in treating viral pneumonia?